TCL Archive ODAC Recommendation for Pertuzumab Signals FDA’s Resolve In Granting Accelerated Approvals September 20, 2013
TCL Archive FDA Auditors Spend Two Weeks At Duke, Nevins Loses Position in Reorganization January 28, 2011
